Preparticipation Screening of Athletes: The Prevalence of Positive Family History

被引:6
作者
Jiravska Godula, Bogna [1 ,2 ]
Jiravsky, Otakar [2 ,3 ]
Pesova, Petra [1 ,2 ]
Jelinek, Libor [1 ]
Sovova, Marketa [1 ]
Moravcova, Katarina [1 ]
Ozana, Jaromir [1 ]
Hudec, Miroslav [2 ,3 ]
Miklik, Roman [2 ,3 ]
Hecko, Jan [2 ,4 ]
Sknouril, Libor [2 ]
Sovova, Eliska [1 ]
机构
[1] Palacky Univ, Fac Med, Krizkovskeho 511 8, Olomouc 77900, Czech Republic
[2] Nemocnice Agel Trinec Podlesi, Sports Cardiol Ctr, Konska 453, Trinec 73961, Czech Republic
[3] Masaryk Univ, Fac Med, Kamenice 735 5, Brno 62500, Czech Republic
[4] VSB Tech Univ Ostrava, Fac Elect Engn & Comp Sci, Ostrava 70833, Czech Republic
关键词
sudden cardiac death; athlete; preparticipation screening; SUDDEN CARDIAC DEATH; PHYSICAL-ACTIVITY; IMPLEMENTATION; HEART; RISK;
D O I
10.3390/jcdd10040183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sudden cardiac death (SCD) is a leading cause of death among athletes, and those with a positive family history (FH) of SCD and/or cardiovascular disease (CVD) may be at increased risk. The primary objective of this study was to assess the prevalence and predictors of positive FH of SCD and CVD in athletes using four widely used preparticipation screening (PPS) systems. The secondary objective was to compare the functionality of the screening systems. In a cohort of 13,876 athletes, 1.28% had a positive FH in at least one PPS system. Multivariate logistic regression analysis identified the maximum heart rate as significantly associated with positive FH (OR = 1.042, 95% CI = 1.027-1.056, p < 0.001). The highest prevalence of positive FH was found using the PPE-4 system (1.20%), followed by FIFA, AHA, and IOC systems (1.11%, 0.89%, and 0.71%, respectively). In conclusion, the prevalence of positive FH for SCD and CVD in Czech athletes was found to be 1.28%. Furthermore, positive FH was associated with a higher maximum heart rate at the peak of the exercise test. The findings of this study revealed significant differences in detection rates between PPS protocols, so further research is needed to determine the optimal method of FH collection.
引用
收藏
页数:11
相关论文
共 50 条
[21]   Prevalence of physiological and pathological electrocardiographic findings in Hungarian athletes [J].
Kiss, O. ;
Sydo, N. ;
Vargha, P. ;
Edes, E. ;
Merkely, G. ;
Sydo, T. ;
Merkely, B. .
ACTA PHYSIOLOGICA HUNGARICA, 2015, 102 (02) :228-237
[22]   ECG diagnostics in competitive athletes. Current implications for preparticipation screening [J].
Pressler, A. ;
Halle, M. .
HERZ, 2012, 37 (05) :474-484
[23]   Preparticipation Screening of Competitive Athletes Seeking Simple Solutions to a Complex Problem [J].
Thompson, Paul D. .
CIRCULATION, 2009, 119 (08) :1072-1074
[24]   Echocardiography in the preparticipation screening: an old topic revisited [J].
Donati, Federica ;
Guicciardi, Claudio ;
Lodi, Elisa ;
Fernando, Fredrick ;
Palermi, Stefano ;
Modena, Maria Grazia ;
Biffi, Alessandro .
JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (05) :297-301
[25]   Can we prevent sudden cardiac death in young athletes: the debate about preparticipation sports screening [J].
Patel, Angira ;
Lantos, John D. .
ACTA PAEDIATRICA, 2011, 100 (10) :1297-1301
[26]   Preparticipation screening and prevention of sudden cardiac death in athletes: Implications for primary care [J].
Morse, Emily ;
Funk, Marjorie .
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2012, 24 (02) :63-69
[27]   Preparticipation screening—the way forward is smart screening [J].
H. Thune Jørstad .
Netherlands Heart Journal, 2018, 26 :120-122
[28]   Accuracy of ECG-inclusive preparticipation screening in athletes: more work to be done [J].
Weiner, Rory B. ;
Baggish, Aaron L. .
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (06) :671-673
[29]   The Validity of Adding ECG to the Preparticipation Screening of Athletes An Evidence Based Literature Review [J].
Alattar, A. ;
Maffulli, N. .
TRANSLATIONAL MEDICINE AT UNISA, 2015, 11 :2-13
[30]   Who Should Interpret Screening Preparticipation ECGs in Young Athletes? [J].
Alexander Hutchinson ;
Nicolas K. Goff ;
Nicole Cain ;
Peter N. Dean ;
Deepak Kamat ;
Lanier Jackson .
Current Treatment Options in Cardiovascular Medicine, 2023, 25 :851-864